GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Qol Holdings Co Ltd (TSE:3034) » Definitions » Other Net Income (Loss)

Qol Holdings Co (TSE:3034) Other Net Income (Loss) : 円-1 Mil (TTM As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Qol Holdings Co Other Net Income (Loss)?

Qol Holdings Co's Other Net Income (Loss) for the three months ended in Dec. 2023 was 円0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was 円-1 Mil.

Qol Holdings Co's annual Other Net Income (Loss) stayed the same from Mar. 2021 (円-1 Mil) to Mar. 2022 (円-1 Mil) but then declined from Mar. 2022 (円-1 Mil) to Mar. 2023 (円-2 Mil).


Qol Holdings Co Other Net Income (Loss) Historical Data

The historical data trend for Qol Holdings Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qol Holdings Co Other Net Income (Loss) Chart

Qol Holdings Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.00 -1.00 -1.00 -1.00 -2.00

Qol Holdings Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.00 -1.00 - - -

Qol Holdings Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qol Holdings Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Qol Holdings Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Qol Holdings Co (TSE:3034) Business Description

Traded in Other Exchanges
N/A
Address
4-3-1, Toranomon, 37th Floor, Shiroyama Trust Tower, Minato-ku, Tokyo, JPN, 105-8452
Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.

Qol Holdings Co (TSE:3034) Headlines

No Headlines